Striking improvement of muscle strength under creatine therapy in a patient with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency

Journal of Inherited Metabolic Disease

Volumn 26, Issue 1, 2003, Pages 67-68

  Korenke, G C ^a,b   Wanders, R J A ^c   Hanefeld, F ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b KLINIKUM OLDENBURG   (Germany)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; CARNITINE; CREATINE; LONG CHAIN FATTY ACID;

3 HYDROXYACYL COENZYME A DEHYDROGENASE DEFICIENCY; ADOLESCENT; ARTICLE; ATAXIA; CASE REPORT; CLINICAL FEATURE; DIET THERAPY; ENZYME DEFICIENCY; FEMALE; HUMAN; MUSCLE STRENGTH; MUSCLE WEAKNESS; TREATMENT OUTCOME;

3-HYDROXYACYL COA DEHYDROGENASES; CHILD; CREATINE; FEMALE; HUMANS; LIPID METABOLISM, INBORN ERRORS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; RECURRENCE; RHABDOMYOLYSIS;

EID: 0038051211     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024031714659     Document Type: Article

References (3)

1. den Boer ME, Wanders RJ, Morris AA, IJlst L, Heymans HS, Wijburg FA (2002) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics 109: 99-104.
2. Tarnopolsky M, Martin J (1999) Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology 52: 854-857.
3. Tyni T, Palotie A, Viinikka L, et al (1997) Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patients. J Pediatr 130: 67-76.